These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 3017628

  • 1. Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke.
    Cone EJ, Johnson RE.
    Clin Pharmacol Ther; 1986 Sep; 40(3):247-56. PubMed ID: 3017628
    [Abstract] [Full Text] [Related]

  • 2. Passive inhalation of marijuana smoke: urinalysis and room air levels of delta-9-tetrahydrocannabinol.
    Cone EJ, Johnson RE, Darwin WD, Yousefnejad D, Mell LD, Paul BD, Mitchell J.
    J Anal Toxicol; 1987 Sep; 11(3):89-96. PubMed ID: 3037193
    [Abstract] [Full Text] [Related]

  • 3. Passive inhalation of marihuana smoke and urinary excretion of cannabinoids.
    Perez-Reyes M, Di Guiseppi S, Mason AP, Davis KH.
    Clin Pharmacol Ther; 1983 Jul; 34(1):36-41. PubMed ID: 6305545
    [Abstract] [Full Text] [Related]

  • 4. Cannabinoids in blood and urine after passive inhalation of Cannabis smoke.
    Mørland J, Bugge A, Skuterud B, Steen A, Wethe GH, Kjeldsen T.
    J Forensic Sci; 1985 Oct; 30(4):997-1002. PubMed ID: 2999292
    [Abstract] [Full Text] [Related]

  • 5. Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
    Johansson E, Halldin MM.
    J Anal Toxicol; 1989 Oct; 13(4):218-23. PubMed ID: 2550702
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cannabinoid concentrations in plasma after passive inhalation of marijuana smoke.
    Mason AP, Perez-Reyes M, McBay AJ, Foltz RL.
    J Anal Toxicol; 1983 Oct; 7(4):172-4. PubMed ID: 6314043
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Passive inhalation of cannabis smoke.
    Law B, Mason PA, Moffat AC, King LJ, Marks V.
    J Pharm Pharmacol; 1984 Sep; 36(9):578-81. PubMed ID: 6149279
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Human urinary excretion profile after smoking and oral administration of [14C]delta 1-tetrahydrocannabinol.
    Johansson E, Gillespie HK, Halldin MM.
    J Anal Toxicol; 1990 Sep; 14(3):176-80. PubMed ID: 2165199
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.
    Wachtel SR, ElSohly MA, Ross SA, Ambre J, de Wit H.
    Psychopharmacology (Berl); 2002 Jun; 161(4):331-9. PubMed ID: 12073159
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH).
    Huestis MA, Henningfield JE, Cone EJ.
    J Anal Toxicol; 1992 Jun; 16(5):283-90. PubMed ID: 1338216
    [Abstract] [Full Text] [Related]

  • 20. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
    Brenneisen R, Meyer P, Chtioui H, Saugy M, Kamber M.
    Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.